"Head and Neck Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)
| Descriptor ID |
D006258
|
| MeSH Number(s) |
C04.588.443
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Head and Neck Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Head and Neck Neoplasms".
This graph shows the total number of publications written about "Head and Neck Neoplasms" by people in this website by year, and whether "Head and Neck Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 7 | 1 | 8 |
| 1997 | 3 | 1 | 4 |
| 1998 | 6 | 0 | 6 |
| 1999 | 13 | 1 | 14 |
| 2000 | 13 | 1 | 14 |
| 2001 | 8 | 3 | 11 |
| 2002 | 8 | 0 | 8 |
| 2003 | 12 | 1 | 13 |
| 2004 | 16 | 1 | 17 |
| 2005 | 13 | 1 | 14 |
| 2006 | 14 | 1 | 15 |
| 2007 | 15 | 2 | 17 |
| 2008 | 17 | 1 | 18 |
| 2009 | 19 | 1 | 20 |
| 2010 | 14 | 4 | 18 |
| 2011 | 15 | 1 | 16 |
| 2012 | 14 | 1 | 15 |
| 2013 | 12 | 2 | 14 |
| 2014 | 33 | 2 | 35 |
| 2015 | 22 | 2 | 24 |
| 2016 | 27 | 3 | 30 |
| 2017 | 23 | 1 | 24 |
| 2018 | 18 | 5 | 23 |
| 2019 | 23 | 2 | 25 |
| 2020 | 18 | 0 | 18 |
| 2021 | 21 | 1 | 22 |
| 2022 | 19 | 0 | 19 |
| 2023 | 21 | 1 | 22 |
| 2024 | 6 | 3 | 9 |
| 2025 | 12 | 0 | 12 |
| 2026 | 10 | 0 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Head and Neck Neoplasms" by people in Profiles.
-
Circulating Tumor DNA in Head and Neck Cancer: A Review From the American Head and Neck Society. JAMA Otolaryngol Head Neck Surg. 2026 Sep 01; 152(9):905-913.
-
Enfortumab Vedotin plus Pembrolizumab as First-line Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Results from EV-202 Cohort 9. Clin Cancer Res. 2026 Aug 14; 32(16):3531-3539.
-
Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation. Ann Oncol. 2026 Oct; 37(10):1437-1449.
-
Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study. J Clin Oncol. 2026 Aug 20; 44(24):2271-2277.
-
Phase 1b study of ABBV-368, tilsotolimod, budigalimab, and nab-paclitaxel in patients with recurrent/metastatic head and neck squamous cell carcinoma. J Immunother Cancer. 2026 Apr 09; 14(4).
-
INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2026 Mar 16; 32(6):1087-1099.
-
Characteristics of patients requiring prolonged mechanical ventilation following head and neck microvascular reconstructive procedures. Eur Arch Otorhinolaryngol. 2026 Jun; 283(6):3893-3903.
-
Obstructive Sleep Apnea Following Head and Neck Chemoradiation: A Scoping Review With Exploratory Meta-Analysis. Head Neck. 2026 06; 48(6):1587-1594.
-
Association of Lead in Drinking Water With Head and Neck Cancer in the United States. Otolaryngol Head Neck Surg. 2026 Feb; 174(2):458-464.
-
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer. Nat Cancer. 2026 Jan; 7(1):98-115.